Media About Us
Proteon Pharmaceuticals is Fighting Salmonella by Attacking it on the Farm
Proteon Pharmaceuticals COO Matthew Tebeau sat down with Christine Corrado from Proactive Investors at the 11th Annual BioTech Showcase in San Francisco.
The Poland-based biotech aims to reduce reliance on antibiotics by using naturally-occurring bacteriophages to prevent and treat infectious diseases.
Developing a bacteriophage platform technology for use in animal health has taken Polish company Proteon Pharmaceuticals a decade to master. Chief operating officer Mathew Tebeau talks to Animal Pharm analyst
Malcolm Flanagan about the firm's past and future.
Netherlands-based investment fund Aqua-Spark is feeding the growth of the sustainable aquaculture movement with an increasingly large and diverse portfolio of investments in the sector.
The Dutch aquaculture fund has made 15 sustainable aquaculture investments over the last two years.
Poland-based Proteon has developed an antibiotic-free method of killing bacteria like salmonella in fish and poultry.
Dutch, pure-play sustainable aquaculture investment fund Aqua-Spark has made two investments that broaden its reach into technologies that have the potential to reduce the use of antibiotics in animal protein production, and to advance fish breeding methodology.
Aqua-Spark, the Dutch venture capital fund, has finalized two investments this week that signal the fund dedicated to the future of aquaculture is moving beyond farms and feed.
Investment fund Aqua-Spark has announced its latest investments to radically improve fish farming by eliminating antibiotics, reducing feed, and enabling farms to safeguard their broodstock.
Two fledgling biotech firms, one of which uses cutting edge technology to eliminate antibiotic use in fish farming and the other improves fish genetics, have secured investments this week.